Abstract 14669: Economic Burden of Acute Coronary Syndromes for Employees and Dependents: Medical and Productivity Costs
Introduction: Acute Coronary Syndromes (ACS) often occurs in working-age individuals; 47% of all ACS patients are younger than 65 years. Limited data exist on the burden of ACS on employees. We attempted to determine the total burden of illness, including the direct and indirect costs associated for employees and their dependents with ACS.
Methods: Medical and pharmacy claims along with short term disability (STD) and long term disability (LTD) claims from 2007-2010 were analyzed using two datasets: Integrated Benefits Institute’s Health and Productivity Benchmarking Database (STD and LTD claims) and IMS LifeLink data (medical and pharmacy claims). Only employees were included for STD and LTD claims, while both employees and dependents were included in medical and pharmacy claims data. Indirect cost analyses consisted of work days lost and wage replacement costs (i.e., productivity losses) for the employers. Direct costs consisted of total all-cause and ACS related health costs (pharmacy and medical) for those newly diagnosed with ACS in the 12 month period following diagnosis. To make direct and indirect costs comparable between the two databases, all healthcare cost estimates were weighted by analytic weights derived from the age and gender distributions to provide a common context.
Results: A total of 37,340 employees had STD or LTD claims for ACS. The majority (77.4%) were male; 94% were less than 65 years of age. The primary industries represented were services, transportation, and manufacturing. Employees with ACS lost on average 60.2 (SEM 0.29) STD and 397 (SEM 8.09) LTD days per disability incident. For employers, the estimated per claim productivity loss for STD and LTD were $7,943±39.7 and $52,473±1,114, respectively. Total annual ACS healthcare costs per employee including out of pocket costs were $8,170±106 with $7,545±104 for annual medical and $625 ±11 for total pharmacy costs. Hospitalizations accounted for 75% of total annual ACS health costs.
Conclusion: These data demonstrate that ACS imposes a substantial economic burden on employees. Long term productivity losses are significant for employers. Disability costs outweigh the direct costs to employers. ACS related hospitalizations represent a large portion of total medical costs.
- © 2012 by American Heart Association, Inc.